Article
BRCA1: An Endocrine and Metabolic Regulator.
Frontiers in endocrinology - 1 Jan 2022
Werner Haim
Abstract excerpt
The breast and ovarian cancer susceptibility gene (BRCA1) is a tumor suppressor whose mutation has been associated with the development of breast, ovarian and, probably, other malignancies at young ages. The BRCA1 gene product participates in multiple biological pathways including the DNA damage response, transcriptional control, cell growth and apoptosis. Inactivating germline mutations of the BRCA1 gene can be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
